Renovaro (RENB) News Today $0.66 -0.05 (-7.45%) Closing price 04:00 PM EasternExtended Trading$0.68 +0.01 (+2.11%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive OncologyMarch 5, 2025 | nasdaq.comRenovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments?March 4, 2025 | insidermonkey.comRenovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreementMarch 3, 2025 | bizjournals.comRenovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive OncologyMarch 3, 2025 | globenewswire.comRenovaro Biosciences Buys AI-Driven BioSymetricsFebruary 27, 2025 | marketwatch.comRenovaro Inc. (RENB) Merges with BioSymetrics to Advance AI-Driven Cancer ResearchFebruary 27, 2025 | msn.comRenovaro Inc: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision MedicineFebruary 27, 2025 | finanznachrichten.deRenovaro BioSciences announces $15M in equity committedFebruary 27, 2025 | markets.businessinsider.comRenovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision MedicineFebruary 26, 2025 | globenewswire.comRenovaro Announces $15 million in Equity CommittedFebruary 26, 2025 | globenewswire.comRenovaro (NASDAQ:RENB) Posts Earnings ResultsRenovaro (NASDAQ:RENB - Get Free Report) released its earnings results on Wednesday. The company reported ($0.02) earnings per share (EPS) for the quarter.February 20, 2025 | marketbeat.comShort Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7%Renovaro Inc. (NASDAQ:RENB - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 5,060,000 shares, an increase of 30.7% from the December 15th total of 3,870,000 shares. Based on an average trading volume of 1,030,000 shares, the short-interest ratio is currently 4.9 days. Currently, 6.6% of the shares of the stock are sold short.January 18, 2025 | marketbeat.comRenovaro BioSciences appoints Fuentes as Chief Financial OfficerJanuary 7, 2025 | markets.businessinsider.comRenovaro BioSciences issues shareholder letter, provides corporate updateJanuary 7, 2025 | markets.businessinsider.comPREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAIJanuary 7, 2025 | businesswire.comRenovaro Biosciences Merges with Predictive OncologyJanuary 7, 2025 | tipranks.comRenovaro Inc. Appoints Nathen Fuentes As CFOJanuary 7, 2025 | markets.businessinsider.comRenovaro Inc: Renovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | finanznachrichten.deRenovaro Taps Nathen Fuentes as Finance ChiefJanuary 7, 2025 | marketwatch.comPredictive Oncology to be acquired by RenovaroJanuary 7, 2025 | markets.businessinsider.comRenovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | finance.yahoo.comRenovaro Issues Shareholder Letter and Provides Corporate UpdateJanuary 7, 2025 | globenewswire.comRenovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | globenewswire.comRenovaro to Acquire Predictive Oncology in All-Stock TransactionJanuary 6, 2025 | tmcnet.comRenovaro to Acquire Predictive Oncology in All-Stock TransactionJanuary 6, 2025 | globenewswire.comRenovaro Inc. (NASDAQ:RENB) Short Interest Up 27.7% in DecemberRenovaro Inc. (NASDAQ:RENB - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 3,870,000 shares, a growth of 27.7% from the November 30th total of 3,030,000 shares. Based on an average trading volume of 869,400 shares, the days-to-cover ratio is presently 4.5 days. Currently, 5.0% of the company's stock are sold short.December 31, 2024 | marketbeat.comRenovaro BioSciences appoints Maurice van Tilburg as CEO of GEDi CubeDecember 31, 2024 | markets.businessinsider.comRenovaro Inc. Appoints Maurice van Tilburg as CEO of GEDi Cube BV to Enhance AI-Driven Cancer DiagnosticsDecember 30, 2024 | quiverquant.comRenovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BVDecember 30, 2024 | globenewswire.comRenovaro BioSciences receives approval of Lumina projectDecember 23, 2024 | markets.businessinsider.comRenovaroCube Receives Approval of Lumina Project by the Eurostars Funding ProgramDecember 23, 2024 | globenewswire.comRenovaro Regains Compliance with NASDAQ Listing RequirementDecember 20, 2024 | globenewswire.comRenovaro Inc: Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease DetectionDecember 20, 2024 | finanznachrichten.deRenovaro werkt samen met Nebul voor AI-gestuurde kankerdetectieDecember 20, 2024 | nl.investing.comRenovaro BioSciences enters into strategic collaboration with NebulDecember 20, 2024 | markets.businessinsider.comRenovaro Inc. Partners with Nebul to Launch GEDi CUBE Next Generation AI Healthcare Cloud SolutionsDecember 20, 2024 | quiverquant.comRenovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease DetectionDecember 20, 2024 | globenewswire.comRenovaro (NASDAQ:RENB) Stock Price Up 2.3% - Here's What HappenedRenovaro (NASDAQ:RENB) Stock Price Up 2.3% - Time to Buy?December 14, 2024 | marketbeat.comRenovaro (NASDAQ:RENB) Trading Up 6.5% - Still a Buy?Renovaro (NASDAQ:RENB) Trading 6.5% Higher - Still a Buy?November 21, 2024 | marketbeat.comRenovaro BioSciences issues shareholder letterNovember 5, 2024 | markets.businessinsider.comRenovaro benoemt nieuwe CEO om kankertechnologie te bevorderenNovember 4, 2024 | nl.investing.comRenovaro Issues Shareholder Letter and Provides Corporate UpdateNovember 4, 2024 | globenewswire.comRenovaro BioSciences files $200M mixed securities shelfOctober 31, 2024 | markets.businessinsider.comRenovaro Names Weinstein as CEO; Four New Board AppointmentsOctober 18, 2024 | marketwatch.comRenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore SequencingOctober 17, 2024 | globenewswire.comRenovaro Inc: Renovaro Announces Strategic Restructuring and Leadership TransitionOctober 17, 2024 | finanznachrichten.deRenovaro Announces Strategic Restructuring and Leadership TransitionOctober 16, 2024 | globenewswire.comRenovaro (NASDAQ:RENB) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comPersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care DiagnosticsSeptember 19, 2024 | markets.businessinsider.comIndependent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer DetectionSeptember 18, 2024 | markets.businessinsider.com Remove Ads Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address RENB Media Mentions By Week RENB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENB News Sentiment▼1.870.68▲Average Medical News Sentiment RENB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENB Articles This Week▼11▲RENB Articles Average Week Remove Ads Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Autolus Therapeutics News Stoke Therapeutics News Keros Therapeutics News Tourmaline Bio News Altimmune News Zevra Therapeutics News Ginkgo Bioworks News Oruka Therapeutics News PureTech Health News Solid Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RENB) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Renovaro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RENB Stock Free RENB Stock Alerts